跳至主要内容
临床试验/NCT00737347
NCT00737347已完成3 期

Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone

Northwestern University2 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2003年9月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
39
试验地点
2
主要终点
change in body weight

研究概览

简要总结

The purpose of the study is to investigate the effectiveness of three lifestyle treatment programs varying in level of intensiveness on prevention of pioglitazone-induced weight gain and to measure the composition of the change in body weight.

详细描述

The three lifestyle interventions were usual care (1 visit), standard care (4 total visits) and intensive care (10 total visits)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
21 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • type 2 diabetes with BMI 27 or greater, glycated hemoglobin 7% or greater

排除标准

  • insulin treated

结局指标

主要结局

change in body weight

时间窗: 24 weeks

次要结局

  • change in body composition(24 weeks)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验